AVR 8.67% $9.78 anteris technologies ltd

Ann: Anti-calcification Comparison Study Interim Results, page-72

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 56 Posts.
    lightbulb Created with Sketch. 16
    LOL
    The history is very ironic and gives insight into the present
    Looks like they sold the longstanding Infusion Business,(that was on the public record as growing and being profitable ) no doubt, as they were sailing close to receivership and had no option but a fire sale to keep the doors open and salaries secured.
    From what I can tell ADAPT has also never turned a profit ?? Why ?? surely this lack of success must reflect on the value of the ADAPT technology
    Looks like a whole series of very poor decisions by this management , underpinned by SP devaluation and overinflated salaries
    My research tells me the critical variable in SP future value is the current management credibility
    I imagine some of management could walk away now with fat bank accounts and this whole project would hold no accountability . Next

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.78
Change
0.780(8.67%)
Mkt cap ! $206.7M
Open High Low Value Volume
$9.00 $9.83 $8.68 $324.0K 35.80K

Buyers (Bids)

No. Vol. Price($)
1 970 $9.50
 

Sellers (Offers)

Price($) Vol. No.
$9.85 1000 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.